ZFA-Logo

Low-Dose Colchizine in Secondary Prophylaxis of Cardiovascular Diseases

german translation / full article

Colchicine 0.5 mg/day administered in addition to statins and other standard secondary prevention therapies appeared effective for the prevention of cardiovascular events in patients with stable coronary disease.


(State: 16.01.2014)

Latest Issue 10/2020

In Focus

  • Challenges of Acute Care
  • Is it Useful to Determine Hormone Levels in Healthy, Symptom-Free Postmenopausal Women?
  • Detecting Victims of Human Trafficking in Family Practice